Omission of axillary dissection according to ACOSOG Z0011: impact on adjuvant treatment recommendations.

Item

http://www.wikidata.org/entity/Q44822009

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Omission of axillary dissectio ...... ant treatment recommendations.

@en

Omission of axillary dissectio ...... ant treatment recommendations.

@nl

type

Item

label

Omission of axillary dissectio ...... ant treatment recommendations.

@en

Omission of axillary dissectio ...... ant treatment recommendations.

@nl

prefLabel

Omission of axillary dissectio ...... ant treatment recommendations.

@en

Omission of axillary dissectio ...... ant treatment recommendations.

@nl

P1476

Omission of axillary dissectio ...... ant treatment recommendations.

@en

P2093

Christof Sohn

http://www.w3.org/2001/XMLSchema#string

Frederik Marmé

http://www.w3.org/2001/XMLSchema#string

Holger Hof

http://www.w3.org/2001/XMLSchema#string

Julia Aigner

http://www.w3.org/2001/XMLSchema#string

Katharina Smetanay

http://www.w3.org/2001/XMLSchema#string

P2860

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database

Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.

Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer.

Outcome analysis of patients with primary breast cancer initially treated at a certified academic breast unit.

P2888

s10434-012-2798-0

P304

1538-1544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-012-2798-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andreas Schneeweiss

Peter Sinn

P577

2013-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1006936612

http://www.w3.org/2001/XMLSchema#string

P698

23389469

http://www.w3.org/2001/XMLSchema#string